Mariner Wealth Advisors (Cincinnati)’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
$2.46M Buy
42,408
+702
+2% +$34.3K 0.14% 103
2018
Q2
$2.02M Buy
41,706
+1,539
+4% +$71.8K 0.12% 104
2018
Q1
$1.87M Buy
40,167
+1,911
+5% +$83K 0.11% 100
2017
Q4
$1.44M Buy
38,256
+2,568
+7% +$94.2K 0.09% 109
2017
Q3
$1.3M Sell
35,688
-90
-0.3% -$3.43K 0.08% 114
2017
Q2
$1.41M Sell
35,778
-780
-2% -$28.5K 0.1% 109
2017
Q1
$1.15M Buy
36,558
+345
+1% +$10.8K 0.08% 114
2016
Q4
$1.13M Buy
+36,213
New +$1.17M 0.09% 116

Other funds holding EW

Mariner Wealth Advisors (Cincinnati)'s EW Position: Q3 2018 in Review

Mariner Wealth Advisors (Cincinnati) increased its Edwards Lifesciences (EW) stake by 1.7% in Q3 2018, buying an estimated $34.3K and bringing the position to 42,408 shares worth $2.46M. The position accounts for 0.14% of the portfolio, ranked #103.

Mariner Wealth Advisors (Cincinnati) first reported a position in EW in Q4 2016 and has held it in 8 quarters since. 852 funds tracked by Wall St. Rank hold EW as of Q3 2018.

  • Mariner Wealth Advisors (Cincinnati) held 42,408 shares of Edwards Lifesciences worth $2.46M as of Q3 2018.
  • Mariner Wealth Advisors (Cincinnati) bought 702 Edwards Lifesciences shares in Q3 2018, an estimated $34.3K.
  • Edwards Lifesciences made up 0.14% of Mariner Wealth Advisors (Cincinnati)'s portfolio in Q3 2018, its #103 holding.
  • Mariner Wealth Advisors (Cincinnati) first reported a position in Edwards Lifesciences in Q4 2016 and has held it in 8 quarters since.
  • 852 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2018.

Based on Mariner Wealth Advisors (Cincinnati)'s 13F filing for Q3 2018, filed 13 Nov 2018.